1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Coronaviruses	_	_	NNS	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	CoVs	_	_	NNS	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	single-strand	_	_	JJ	_	_	_	_	_
7	plus	_	_	CC	_	_	_	_	_
8	RNA	_	_	NN	_	_	_	_	_
9	viruses	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	belong	_	_	VBP	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	order	_	_	NN	_	_	_	_	_
16	Nidovirales	_	_	NNP	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	CoVs	_	_	NNS	_	_	_	_	_
2	normally	_	_	RB	_	_	_	_	_
3	infect	_	_	VBP	_	_	_	_	_
4	epithelial	_	_	JJ	_	_	_	_	_
5	cells	_	_	NNS	_	_	_	_	_
6	such	_	_	JJ	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	respiratory	_	_	JJ	_	_	_	_	_
9	epithelial	_	_	JJ	_	_	_	_	_
10	cells	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	intestinal	_	_	JJ	_	_	_	_	_
13	epithelial	_	_	JJ	_	_	_	_	_
14	cells	_	_	NNS	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	kidney	_	_	NN	_	_	_	_	_
17	epithelial	_	_	JJ	_	_	_	_	_
18	cells	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	causes	_	_	VBZ	_	_	_	_	_
22	respiratory	_	_	JJ	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	intestinal	_	_	JJ	_	_	_	_	_
25	tract	_	_	NN	_	_	_	_	_
26	diseases	_	_	NNS	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	various	_	_	JJ	_	_	_	_	_
29	levels	_	_	NNS	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	severity	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Human	_	_	JJ	_	_	_	_	_
2	coronavirus	_	_	NN	_	_	_	_	_
3	229E	_	_	CD	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	HCoV-229E	_	_	NN	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	main	_	_	JJ	_	_	_	_	_
10	cause	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	common	_	_	JJ	_	_	_	_	_
14	cold	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	while	_	_	IN	_	_	_	_	_
17	severe	_	_	JJ	_	_	_	_	_
18	acute	_	_	JJ	_	_	_	_	_
19	respiratory	_	_	JJ	_	_	_	_	_
20	syndrome	_	_	NN	_	_	_	_	_
21	coronavirus	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	SARS-CoV	_	_	NNP	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	Middle	_	_	NNP	_	_	_	_	_
27	East	_	_	NNP	_	_	_	_	_
28	respiratory	_	_	NN	_	_	_	_	_
29	syndrome	_	_	NN	_	_	_	_	_
30	coronavirus	_	_	NN	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	MERS-CoV	_	_	NNP	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	cause	_	_	VBP	_	_	_	_	_
35	severe	_	_	JJ	_	_	_	_	_
36	respiratory	_	_	JJ	_	_	_	_	_
37	disease	_	_	NN	_	_	_	_	_
38	that	_	_	WDT	_	_	_	_	_
39	can	_	_	MD	_	_	_	_	_
40	be	_	_	VB	_	_	_	_	_
41	life-threatening	_	_	JJ	_	_	_	_	_
42	to	_	_	TO	_	_	_	_	_
43	humans	_	_	NNS	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	some	_	_	DT	_	_	_	_	_
4	CoVs-like	_	_	JJ	_	_	_	_	_
5	mouse	_	_	NN	_	_	_	_	_
6	hepatitis	_	_	NN	_	_	_	_	_
7	virus	_	_	NN	_	_	_	_	_
8	John	_	_	NNP	_	_	_	_	_
9	Howard	_	_	NNP	_	_	_	_	_
10	Mueller	_	_	NNP	_	_	_	_	_
11	strain	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	MHV-JHM	_	_	NNP	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	infect	_	_	VBP	_	_	_	_	_
16	oligodendrocytes	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	astrocytes	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	microglia	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	cause	_	_	VB	_	_	_	_	_
23	acute	_	_	JJ	_	_	_	_	_
24	encephalomyelitis	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Additionally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	human	_	_	JJ	_	_	_	_	_
4	coronavirus	_	_	NN	_	_	_	_	_
5	OC43	_	_	NNP	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	HCoV-OC43	_	_	NNP	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	can	_	_	MD	_	_	_	_	_
10	also	_	_	RB	_	_	_	_	_
11	reach	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	central	_	_	JJ	_	_	_	_	_
14	nervous	_	_	JJ	_	_	_	_	_
15	system	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	CNS	_	_	NNP	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	by	_	_	IN	_	_	_	_	_
20	intranasal	_	_	JJ	_	_	_	_	_
21	inoculation	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	BALB/c	_	_	NNP	_	_	_	_	_
24	mice	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	which	_	_	WDT	_	_	_	_	_
27	causes	_	_	VBZ	_	_	_	_	_
28	encephalitis	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	release	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	cytokines	_	_	NNS	_	_	_	_	_
5	such	_	_	JJ	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	TNF-α	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	interleukin-1β	_	_	NN	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	IL-1β	_	_	NN	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	interleukin-6	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	IL-6	_	_	NNP	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	closely	_	_	RB	_	_	_	_	_
20	associated	_	_	VBN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	encephalitis	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Infectious	_	_	JJ	_	_	_	_	_
2	bronchitis	_	_	NN	_	_	_	_	_
3	virus	_	_	NN	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	IBV	_	_	NNP	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	belongs	_	_	VBZ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	gamma-coronavirus	_	_	NN	_	_	_	_	_
11	group	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	γ-CoV	_	_	NNP	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	which	_	_	WDT	_	_	_	_	_
17	causes	_	_	VBZ	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	highly	_	_	RB	_	_	_	_	_
20	contagious	_	_	JJ	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	acute	_	_	JJ	_	_	_	_	_
23	viral	_	_	JJ	_	_	_	_	_
24	respiratory	_	_	JJ	_	_	_	_	_
25	disease	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	chickens	_	_	NNS	_	_	_	_	_
28	that	_	_	WDT	_	_	_	_	_
29	has	_	_	VBZ	_	_	_	_	_
30	caused	_	_	VBN	_	_	_	_	_
31	great	_	_	JJ	_	_	_	_	_
32	economic	_	_	JJ	_	_	_	_	_
33	losses	_	_	NNS	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	poultry	_	_	NN	_	_	_	_	_
37	industry	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	present	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	QX-type	_	_	NNP	_	_	_	_	_
5	IBV	_	_	NNP	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	epidemic	_	_	JJ	_	_	_	_	_
8	worldwide	_	_	RB	_	_	_	_	_
9	;	_	_	:	_	_	_	_	_
10	it	_	_	PRP	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	damage	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	respiratory	_	_	JJ	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	digestive	_	_	JJ	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	urogenital	_	_	JJ	_	_	_	_	_
19	systems	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	chickens	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Besides	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	because	_	_	IN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	severe	_	_	JJ	_	_	_	_	_
6	damage	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	respiratory	_	_	JJ	_	_	_	_	_
9	mucosa	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	infected	_	_	VBN	_	_	_	_	_
12	chickens	_	_	NNS	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	susceptible	_	_	JJ	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	secondary	_	_	JJ	_	_	_	_	_
17	infection	_	_	NN	_	_	_	_	_
18	by	_	_	IN	_	_	_	_	_
19	mycoplasma	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	bacteria	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	other	_	_	JJ	_	_	_	_	_
25	pathogens	_	_	NNS	_	_	_	_	_
26	causing	_	_	VBG	_	_	_	_	_
27	high	_	_	JJ	_	_	_	_	_
28	mortality	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	All	_	_	DT	_	_	_	_	_
2	CoV	_	_	NN	_	_	_	_	_
3	virions	_	_	NNS	_	_	_	_	_
4	encode	_	_	VBP	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	set	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	four	_	_	CD	_	_	_	_	_
9	structural	_	_	JJ	_	_	_	_	_
10	proteins	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	namely	_	_	RB	_	_	_	_	_
13	;	_	_	:	_	_	_	_	_
14	spike	_	_	NN	_	_	_	_	_
15	glycoprotein	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	S	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	small	_	_	JJ	_	_	_	_	_
21	envelope	_	_	NN	_	_	_	_	_
22	protein	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	E	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	membrane	_	_	NN	_	_	_	_	_
28	glycoprotein	_	_	NN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	M	_	_	NN	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	nucleocapsid	_	_	NN	_	_	_	_	_
34	proteins	_	_	NNS	_	_	_	_	_
35	(	_	_	-LRB-	_	_	_	_	_
36	N	_	_	NNP	_	_	_	_	_
37	)	_	_	-RRB-	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	S	_	_	POS	_	_	_	_	_
2	protein	_	_	NN	_	_	_	_	_
3	belongs	_	_	VBZ	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	class	_	_	NN	_	_	_	_	_
7	I	_	_	PRP	_	_	_	_	_
8	fusion	_	_	NN	_	_	_	_	_
9	proteins	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	located	_	_	VBN	_	_	_	_	_
12	at	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	surface	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	virion	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	trimeric	_	_	JJ	_	_	_	_	_
3	S	_	_	POS	_	_	_	_	_
4	glycoprotein	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	class	_	_	NN	_	_	_	_	_
8	I	_	_	PRP	_	_	_	_	_
9	fusion	_	_	NN	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	mediates	_	_	VBZ	_	_	_	_	_
13	attachment	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	host	_	_	NN	_	_	_	_	_
17	receptor	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	S	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	typically	_	_	RB	_	_	_	_	_
4	cleaved	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	host	_	_	NN	_	_	_	_	_
8	cell	_	_	NN	_	_	_	_	_
9	furin-like	_	_	JJ	_	_	_	_	_
10	protease	_	_	NN	_	_	_	_	_
11	into	_	_	IN	_	_	_	_	_
12	two	_	_	CD	_	_	_	_	_
13	separate	_	_	JJ	_	_	_	_	_
14	polypeptides	_	_	NNS	_	_	_	_	_
15	named	_	_	VBN	_	_	_	_	_
16	S1	_	_	NNP	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	S2	_	_	NNP	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	S1	_	_	NNP	_	_	_	_	_
2	makes	_	_	VBZ	_	_	_	_	_
3	up	_	_	RP	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	large	_	_	JJ	_	_	_	_	_
6	receptor-binding	_	_	JJ	_	_	_	_	_
7	domain	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	S	_	_	POS	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	while	_	_	IN	_	_	_	_	_
14	S2	_	_	NNP	_	_	_	_	_
15	forms	_	_	VBZ	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	stalk	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	spike	_	_	NN	_	_	_	_	_
21	molecule	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	an	_	_	DT	_	_	_	_	_
4	extra	_	_	JJ	_	_	_	_	_
5	furin	_	_	NN	_	_	_	_	_
6	cleavage	_	_	NN	_	_	_	_	_
7	site	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	furin-S2′	_	_	NNP	_	_	_	_	_
10	site	_	_	NN	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	upstream	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	fusion	_	_	NN	_	_	_	_	_
16	peptide	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	S2	_	_	NN	_	_	_	_	_
20	subunit	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	some	_	_	DT	_	_	_	_	_
23	CoVs	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	which	_	_	WDT	_	_	_	_	_
26	has	_	_	VBZ	_	_	_	_	_
27	been	_	_	VBN	_	_	_	_	_
28	reported	_	_	VBN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	influence	_	_	VB	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	mechanism	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	invasion	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	host	_	_	NN	_	_	_	_	_
37	cells	_	_	NNS	_	_	_	_	_
38	by	_	_	IN	_	_	_	_	_
39	CoVs	_	_	NNP	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	original	_	_	JJ	_	_	_	_	_
4	sequence	_	_	NN	_	_	_	_	_
5	PTKR/S	_	_	NNP	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	SARS-CoV	_	_	NNP	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	replaced	_	_	VBN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	RRKR/S	_	_	NNP	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	SARS-CoV	_	_	NNP	_	_	_	_	_
14	could	_	_	MD	_	_	_	_	_
15	invade	_	_	VB	_	_	_	_	_
16	susceptible	_	_	JJ	_	_	_	_	_
17	cells	_	_	NNS	_	_	_	_	_
18	while	_	_	IN	_	_	_	_	_
19	no	_	_	RB	_	_	_	_	_
20	longer	_	_	RBR	_	_	_	_	_
21	relying	_	_	VBG	_	_	_	_	_
22	on	_	_	IN	_	_	_	_	_
23	cathepsin	_	_	NN	_	_	_	_	_
24	L.	_	_	NNP	_	_	_	_	_
25	Additionally	_	_	RB	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	after	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	S2′	_	_	NNP	_	_	_	_	_
30	site	_	_	NN	_	_	_	_	_
31	mutated	_	_	VBD	_	_	_	_	_
32	into	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	furin-S2′	_	_	JJ	_	_	_	_	_
35	site	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	MHV-A59	_	_	NNP	_	_	_	_	_
39	strain	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	MHV	_	_	NNP	_	_	_	_	_
42	can	_	_	MD	_	_	_	_	_
43	fuse	_	_	VB	_	_	_	_	_
44	with	_	_	IN	_	_	_	_	_
45	susceptible	_	_	JJ	_	_	_	_	_
46	cells	_	_	NNS	_	_	_	_	_
47	in	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	early	_	_	JJ	_	_	_	_	_
50	endosome	_	_	NN	_	_	_	_	_
51	,	_	_	,	_	_	_	_	_
52	but	_	_	CC	_	_	_	_	_
53	not	_	_	RB	_	_	_	_	_
54	lysosome	_	_	NN	_	_	_	_	_
55	,	_	_	,	_	_	_	_	_
56	without	_	_	IN	_	_	_	_	_
57	requiring	_	_	VBG	_	_	_	_	_
58	lysosomal	_	_	JJ	_	_	_	_	_
59	enzymes	_	_	NNS	_	_	_	_	_
60	such	_	_	JJ	_	_	_	_	_
61	as	_	_	IN	_	_	_	_	_
62	MERS-CoV	_	_	NNP	_	_	_	_	_
63	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	for	_	_	IN	_	_	_	_	_
3	IBV	_	_	NNP	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	furin-S2′	_	_	NNP	_	_	_	_	_
7	site	_	_	NN	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	determinant	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	cellular	_	_	JJ	_	_	_	_	_
13	adaptation	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	IBV-Beaudette	_	_	NNP	_	_	_	_	_
17	strain	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	If	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	motif	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	lacking	_	_	VBG	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	IBV-Beaudette	_	_	NNP	_	_	_	_	_
9	strain	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	normally	_	_	RB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	only	_	_	JJ	_	_	_	_	_
16	IBV	_	_	NNP	_	_	_	_	_
17	strain	_	_	NN	_	_	_	_	_
18	able	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	adapt	_	_	VB	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	Vero	_	_	NNP	_	_	_	_	_
24	cell	_	_	NN	_	_	_	_	_
25	line	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	can	_	_	MD	_	_	_	_	_
28	no	_	_	RB	_	_	_	_	_
29	longer	_	_	RBR	_	_	_	_	_
30	grow	_	_	VB	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	these	_	_	DT	_	_	_	_	_
33	cells	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Most	_	_	RBS	_	_	_	_	_
2	basic	_	_	JJ	_	_	_	_	_
3	research	_	_	NN	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	IBV	_	_	NNP	_	_	_	_	_
6	performed	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	date	_	_	NN	_	_	_	_	_
9	has	_	_	VBZ	_	_	_	_	_
10	been	_	_	VBN	_	_	_	_	_
11	based	_	_	VBN	_	_	_	_	_
12	on	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	IBV-Beaudette	_	_	NNP	_	_	_	_	_
15	strain	_	_	NN	_	_	_	_	_
16	;	_	_	:	_	_	_	_	_
17	therefore	_	_	RB	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	much	_	_	RB	_	_	_	_	_
20	remains	_	_	VBZ	_	_	_	_	_
21	unknown	_	_	JJ	_	_	_	_	_
22	about	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	pathogenic	_	_	JJ	_	_	_	_	_
25	mechanism	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	QX-type	_	_	NNP	_	_	_	_	_
28	IBV	_	_	NNP	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	rescued	_	_	VBD	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	mutant	_	_	JJ	_	_	_	_	_
7	QX-type	_	_	NNP	_	_	_	_	_
8	IBV	_	_	NNP	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	furin-S2′	_	_	NNP	_	_	_	_	_
12	site	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	compared	_	_	VBD	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	pathogenicity	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	mutant	_	_	JJ	_	_	_	_	_
20	IBV	_	_	NNP	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	its	_	_	PRP$	_	_	_	_	_
23	parental	_	_	JJ	_	_	_	_	_
24	virus	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	also	_	_	RB	_	_	_	_	_
3	further	_	_	RBR	_	_	_	_	_
4	investigated	_	_	VBD	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	tissue	_	_	NN	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	cell	_	_	NN	_	_	_	_	_
9	tropism	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	clarified	_	_	VBD	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	biological	_	_	JJ	_	_	_	_	_
7	significance	_	_	NN	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	an	_	_	DT	_	_	_	_	_
10	immunoprotection	_	_	NN	_	_	_	_	_
11	experiment	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	function	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	S	_	_	POS	_	_	_	_	_
5	protein	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	QX-type	_	_	NNP	_	_	_	_	_
8	IBV	_	_	NNP	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	demonstrated	_	_	VBN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	which	_	_	WDT	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	more	_	_	RBR	_	_	_	_	_
15	valuable	_	_	JJ	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	poultry	_	_	NN	_	_	_	_	_
18	than	_	_	IN	_	_	_	_	_
19	research	_	_	NN	_	_	_	_	_
20	about	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	IBV-Beaudette	_	_	NNP	_	_	_	_	_
23	strain	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_

